Skip to main content
logo
ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.060
-0.040 (-1.90%)
At close: Aug 10, 2026, 4:00 PM EDT
2.055
-0.005 (-0.24%)
After-hours: Aug 10, 2026, 7:34 PM EDT

ALX Oncology Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2856189744461872
Market Cap Growth
687.51%-30.63%-88.09%61.51%-47.20%-74.61%
Enterprise Value
157.6626.42-29.25570.69203.69508.55
Last Close Price
2.061.131.6714.8911.2721.49

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.132.370.783.921.752.40
P/TBV Ratio
1.322.330.773.371.742.39

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
--0.21---
EV/EBIT Ratio
--0.21---
EV/FCF Ratio
--0.24---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.170.080.050.040
Net Debt / Equity Ratio
-0.94-1.35-1.04-0.91-0.97-1.00
Net Debt / EBITDA Ratio
1.570.340.831.022.024.36
Net Debt / FCF Ratio
1.810.420.961.322.835.29
Quick Ratio
9.351.826.915.089.4023.78
Current Ratio
9.712.077.265.249.5724.00
Return on Equity (ROE)
-99.76%-145.70%-88.91%-70.97%-39.42%-21.05%
Return on Assets (ROA)
-75.09%-100.59%-73.00%-62.03%-37.10%-20.48%
Return on Invested Capital (ROIC)
-607.04%--2301.57%-1464.06%-4225.94%-
Return on Capital Employed (ROCE)
-91.45%-127.04%-84.85%-70.26%-39.63%-21.03%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-61.42%-2.84%-21.37%-5.62%-0.97%-118.05%
Total Shareholder Return
-61.42%-2.84%-21.37%-5.62%-0.97%-118.05%
SEC Filings: 10-K · 10-Q